
|
|
PREFACE
PETER KOEHLER Freisling, Germany (+) |

|
|
ANALYTICAL SESSION |

|
|
DR. RENATE VAN ECKERT Wellington, New Zealand (+)
Differential immunoreactivity of selected monoclonal antibodies towards a reference gliadin. |

|
|
CLYDE DON The Netherlands (+)
Report of the Protein Technical Committee of AACC International |

|
|
PETER KOEHLER Freising, Germany (+)
Collaborative Study on Gluten Determination Using Sandwich and Competitive R5 ELISA Kits. |

|
|
LUUD GILISEN Wageningen, The Netherlands (+)
Prolamins in Wageningen
Food-related strategies towards reduction of gluten intolerance and gluten sensitivity |

|
|
RICHARD FIELDER United Kigdom (+)
Romer labs
Detection of toxic fragments from gluten using a new monoclonal antibody-based test |

|
|
PAIVI KANERVA Helsinki, Finland (+)
Analysis of oat and buckwheat proteins by sandwich R5 ELISA |

|
|
YLVA SJOGREN BOLIN Sweden (+)
Gluten and nutritional content in a ”gluten-free” diet composed according to the Swedish nutritional recommendations |

|
|
THERESA SCHWALB Freising, Germany (+)
Gluten-Specific Peptidase Activity of Different Cereal Species and Cultivars Induced by Germination |

|
|
CLINICAL SESSION |

|
|
FERNANDO CHIRDO La Plata, Argentine (+)
CXCR3 / CXCL10 axis. Role in Coeliac Disease pathogenesis |

|
|
PAUL CICLITIRA London, United Kingdom (+)
Refractory celiac disease outcomes in a single tertiary referral centre. |

|
|
MARGARET DUNNE Dublin, Ireland (+)
The role of the innate immune system in coeliac disease |

|
|
THOMAS MOTHESLeipzig, Germany (+)
When do antibody assays definitely predict coeliac disease? |

|
|
THOMAS MOTHES Leipzig, Germany (+)
New monoclonal antibodies against human tissue transglutaminase |

|
|
ASTRID KRUIZINGA Zeist, The Netherlands (+)
Risk assessment of gluten exposure among celiac patients |

|
|
DETLEF SCHUPPAN Mainz, Germany (+)
Cereal triggers of innate inflammation |

|
|
Symposium: Gluten in food technology
CHAIR: PETER KOEHLER |

|
|
JUSSI LOPONEN Helsinki, Finland (+)
Gluten processing in food technology |

|
|
ELKE ARENDT Cork, Ireland (+)
Replacing gluten as a functional constituent in baked goods
Advances in the production of gluten-free breads |

|
|
Current developments concerning gluten analysis
and clinical developments. Statments by partipating organisations, representatives from industry and guest |

|
|
HERTHA DEUTSCH Vienna, Austria (+)
CODEX: labelling and symbol affairs. |

|
|
MARTIN STERNTubingen, Germany (+)
Coeliac disease and evidence based regulations of gluten free food. The Prolamin Working Group 1985-2011. |

|
|
ACTION PLAN |

|
|
MARTIN STERN and PETER KOEHLER (+)
Defining the Action Plan for next period |
|